{
  "id": "Leiden_Clinical_Prediction_Rule_guideline.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-11-24",
      "name": "Maryam Razavi",
      "organisation": "CambioCDS",
      "email": "maryam.razavi@cambio.se"
    },
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To diagnose rheumatoid arthritis. ",
        "keywords": [
          "arthritis",
          "rheumatoid arthritis",
          "Rheumatoid factor"
        ],
        "use": "Use in patients with recent-onset undifferentiated arthritis.\nVariables and points are as following: \n_ Age, years: Multiply by 0.02\n- Sex: Male=0, Female=1\n- Distribution of involved joints: Small joints in hands/feet=0.5, Upper extremities only=1, Upper and lower extremities=1.5, Other=0\n- Symmetric distribution: No=0, Yes=0.5\n- Duration of morning stiffness: <30 min=0, 30-59 min=0.5, ≥60 min=1\n- Number of tender joints (out of 68): <4=0, 4-10=0.5, ≥11=1\n- Number of swollen joints (out of 66): <4=0, 4-10=0.5, ≥11=1\n- C-reactive protein level, mg/L: <5=0, 5-50=0.5, ≥51=1.5\n- Rheumatoid factor: Negative=0, Positive=1\n- Anti-CCP antibodies: Negative=0, Positive=2\n\nFormula: \nAge x 0.02 + sum of all other selected points\n\nInterpretation: \nScore ≤6.0= Risk group Low\nScore >6.0 and <8.0= Risk group Indeterminate\nScore ≥8.0= Risk group High",
        "copyright": "CambioCDS"
      }
    },
    "other_details": {
      "references": "1. Van der helm-van mil AH, Le cessie S, Van dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007;56(2):433-40.\n2. Van der helm-van mil AH, Detert J, Le cessie S, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum. 2008;58(8):2241-7.\n3. Mcnally E, Keogh C, Galvin R, Fahey T. Diagnostic accuracy of a clinical prediction rule (CPR) for identifying patients with recent-onset undifferentiated arthritis who are at a high risk of developing rheumatoid arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;43(4):498-507."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0003": {
        "id": "gt0003",
        "model_id": "openEHR-EHR-OBSERVATION.basic_demographic_vitd.v1",
        "template_id": "openEHR-EHR-OBSERVATION.basic_demographic_vitd.v1",
        "type": "INPUT",
        "elements": {
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0013]"
          }
        }
      },
      "gt0006": {
        "id": "gt0006",
        "model_id": "openEHR-EHR-OBSERVATION.leiden_clinical_prediction_rule.v0",
        "template_id": "openEHR-EHR-OBSERVATION.leiden_clinical_prediction_rule.v0",
        "type": "INPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0012]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0015]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          },
          "gt0012": {
            "id": "gt0012",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0023]"
          },
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0027]"
          },
          "gt0014": {
            "id": "gt0014",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0031]"
          },
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0034]"
          }
        }
      },
      "gt0016": {
        "id": "gt0016",
        "model_id": "openEHR-EHR-OBSERVATION.leiden_clinical_prediction_rule.v0",
        "template_id": "openEHR-EHR-OBSERVATION.leiden_clinical_prediction_rule.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0017": {
            "id": "gt0017",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0037]"
          },
          "gt0018": {
            "id": "gt0018",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0038]"
          }
        }
      }
    },
    "rules": {
      "gt0002": {
        "id": "gt0002",
        "priority": 4,
        "when": [
          "$gt0005|Age|!=null",
          "$gt0007|Sex|!=null",
          "$gt0008|Distribution of involved joints|!=null",
          "$gt0009|Symmetric distribution|!=null",
          "$gt0005|Age|.unit=='a'",
          "$gt0010|Duration of morning stiffness|!=null",
          "$gt0011|Number of tender joints (out of 68)|!=null",
          "$gt0012|Number of swollen joints (out of 66)|!=null",
          "$gt0013|C-reactive protein level, mg/L|!=null",
          "$gt0014|Rheumatoid factor|!=null",
          "$gt0015|Anti-CCP antibodies|!=null"
        ],
        "then": [
          "$gt0017|Points|.magnitude=($gt0005.magnitude*0.02)+$gt0007.value+($gt0008.value/2)+($gt0009.value/2)+($gt0010.value/2)+($gt0011.value/2)+($gt0012.value/2)+($gt0013.value/2)+$gt0014.value+$gt0015.value",
          "$gt0017|Points|.precision=1",
          "$gt0017|Points|.unit='1'"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 3,
        "when": [
          "$gt0017|Points|<=6,1"
        ],
        "then": [
          "$gt0018|Risk group|='Low. NPV 83%'"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 2,
        "when": [
          "$gt0017|Points|>6,1",
          "$gt0017|Points|<8,1"
        ],
        "then": [
          "$gt0018|Risk group|='Intermediate. '"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 1,
        "when": [
          "$gt0017|Points|>=8,1"
        ],
        "then": [
          "$gt0018|Risk group|='High. PPV 97%'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Leiden Clinical Prediction Rule",
            "description": "Leiden Clinical Prediction Rule for Undifferentiated Arthritis"
          },
          "gt0002": {
            "id": "gt0002",
            "text": "Set Leiden Clinical Prediction Rule"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Age",
            "description": "Age in years, and for babies: months, weeks or days"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Sex",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Distribution of involved joints",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Symmetric distribution",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Duration of morning stiffness",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Number of tender joints (out of 68)",
            "description": "*"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Number of swollen joints (out of 66)",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "C-reactive protein level, mg/L",
            "description": "*"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Rheumatoid factor",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Anti-CCP antibodies",
            "description": "*"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Points",
            "description": "*"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Risk group",
            "description": "*"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Set Low risk group"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Set Intermediate risk group"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Set High risk group"
          }
        }
      }
    }
  }
}